Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,318 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Health Evaluation of Abilify Long-term Therapy

NCT00520650

Conditions
Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • National Taiwan University Hospital Yun-Lin Branch Douliu, Taiwan
  • Cardinal Tien Hospital Hsin Chu Mercy Branch Hsinchu, Taiwan
  • Buddhist Tzu Chi General Hospital Hualien City, Taiwan
View Trial Details
Completed

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

NCT00418171

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Pfizer Investigational Site San Bernardino, California, United States
  • Pfizer Investigational Site ‘Aiea, Hawaii, United States
  • Pfizer Investigational Site Schaumburg, Illinois, United States
  • Pfizer Investigational Site Grants Pass, Oregon, United States
View Trial Details
Completed

A Study for Patients With Schizophrenia

NCT00520923

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Banfield, Argentina
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lanús Este, Argentina
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munro, Argentina
View all 35 locations
View Trial Details
Completed

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

NCT00401973

Conditions
Mental Disorders, Psychotic Disorders, Schizoaffective Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. National City, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Canton, Ohio, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Johnson City, Tennessee, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States
View all 15 locations
View Trial Details

Related conditions